Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wild

Showing results (331-340 of 430) with videos related to

Pageof 43
Sort By:
European Journal of Preventive Cardiology|March 28, 2026
Using population-wide electronic health records for timely contemporary assessment of cardiovascular disease risk prediction model performance: COVID-19 impact on the SCORE2 modelsCarmen Petitjean, Spencer J Keene, Thomas Bolton, et al.
Diabetes Care|March 21, 2023
Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety StudyHuan Wang, Ruth L M Cordiner, Yu Huang, et al.
BMJ Medicine|August 26, 2024
Multimorbidity and adverse outcomes following emergency department attendance: population based cohort studyMichael C Blayney, Matthew J Reed, John A Masterson, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approachR A Smith, J Barbosa, C L Blum, et al.
Plos Genetics|January 13, 2010
Modeling of environmental effects in genome-wide association studies identifies SLC2A2 and HP as novel loci influencing serum cholesterol levelsWilmar Igl, Asa Johansson, James F Wilson, et al.
The Lancet. Diabetes & Endocrinology|December 18, 2025
11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050Irini Genitsaridi, Paraskevi Salpea, Agus Salim, et al.
European Journal of Human Genetics : EJHG|February 16, 2012
Genome-wide analysis of epistasis in body mass index using multiple human populationsWen-Hua Wei, Gib Hemani, Attila Gyenesei, et al.
Plos Medicine|October 12, 2012
Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage studyShona J Livingstone, Helen C Looker, Eleanor J Hothersall, et al.
Diabetologia|September 5, 2012
Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugsH M Colhoun, S J Livingstone, H C Looker, et al.
JAMA|January 7, 2015
Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010Shona J Livingstone, Daniel Levin, Helen C Looker, et al.
Pageof 43

Showing results (331-340 of 430) with videos related to

Sort By:
Pageof 43
European Journal of Preventive Cardiology|March 28, 2026
Using population-wide electronic health records for timely contemporary assessment of cardiovascular disease risk prediction model performance: COVID-19 impact on the SCORE2 modelsCarmen Petitjean, Spencer J Keene, Thomas Bolton, et al.
Diabetes Care|March 21, 2023
Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety StudyHuan Wang, Ruth L M Cordiner, Yu Huang, et al.
BMJ Medicine|August 26, 2024
Multimorbidity and adverse outcomes following emergency department attendance: population based cohort studyMichael C Blayney, Matthew J Reed, John A Masterson, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approachR A Smith, J Barbosa, C L Blum, et al.
Plos Genetics|January 13, 2010
Modeling of environmental effects in genome-wide association studies identifies SLC2A2 and HP as novel loci influencing serum cholesterol levelsWilmar Igl, Asa Johansson, James F Wilson, et al.
The Lancet. Diabetes & Endocrinology|December 18, 2025
11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050Irini Genitsaridi, Paraskevi Salpea, Agus Salim, et al.
European Journal of Human Genetics : EJHG|February 16, 2012
Genome-wide analysis of epistasis in body mass index using multiple human populationsWen-Hua Wei, Gib Hemani, Attila Gyenesei, et al.
Plos Medicine|October 12, 2012
Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage studyShona J Livingstone, Helen C Looker, Eleanor J Hothersall, et al.
Diabetologia|September 5, 2012
Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugsH M Colhoun, S J Livingstone, H C Looker, et al.
JAMA|January 7, 2015
Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010Shona J Livingstone, Daniel Levin, Helen C Looker, et al.
Pageof 43